HMGB1-mediated autophagy decreases sensitivity to oxymatrine in SW982 human synovial sarcoma cells
Yongsong Cai1, Peng Xu2, Le Yang2
1Department of Orthopaedics of the First Affiliated Hospital, Xi'an Jiaotong University Health Science Center, Xi'an, 710061, China.
Abstract:
Oxymatrine (OMT) is a type of alkaloid extracted from a traditional Chinese medicinal herb, Sophora flavescens. Although the antitumor activities of OMT have been observed in various cancers, there are no reports regarding the effects of OMT on human synovial sarcoma. In the present study, we analyzed the antitumor activities of OMT in SW982 human synovial sarcoma cells and determine whether high mobility group box protein 1 (HMGB1)-mediated autophagy was associated with its therapeutic effects. We found that OMT exhibited antitumor activity in SW982 cells and facilitated increases in autophagy. Inhibition of autophagy by 3-MA or ATG7 siRNA increased the level of apoptosis, which indicated that OMT-induced autophagy protected cells from the cytotoxicity of OMT. Administration of OMT to SW982 cells increased the expression of HMGB1. When HMGB1 was inhibited via HMGB1-siRNA, OMT-induced autophagy was decreased, and apoptosis was increased. Furthermore, we found that HMGB1-siRNA significantly increased the expression of p-Akt and p-mTOR. OMT-induced autophagy may be mediated by the Akt/mTOR pathway, and HMGB1 plays a vital role in the regulation of autophagy. Therefore, we believe that combining OMT with an inhibitor of autophagy or HMGB1 may make OMT more effective in the treatment of human synovial sarcoma.
Insights
Oxymatrine (OMT) shows antitumor effects in human synovial sarcoma cells by increasing autophagy. This autophagy, mediated by high mobility group box protein 1 (HMGB1), protects cells; inhibiting it enhances OMT
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Oxymatrine (OMT), an alkaloid from Sophora flavescens, has known antitumor properties.
- The effects of OMT on human synovial sarcoma and its underlying mechanisms remain uninvestigated.
Purpose of the Study:
- To investigate the antitumor activity of OMT on SW982 human synovial sarcoma cells.
- To determine the role of high mobility group box protein 1 (HMGB1)-mediated autophagy in OMT's therapeutic effects.
Main Methods:
- Cell culture of SW982 human synovial sarcoma cells.
- Treatment with Oxymatrine (OMT), autophagy inhibitors (3-MA, ATG7 siRNA), and HMGB1 inhibitors (HMGB1-siRNA).
- Analysis of cell apoptosis, autophagy markers, and protein expression (HMGB1, p-Akt, p-mTOR).
Main Results:
- OMT demonstrated antitumor activity and induced autophagy in SW982 cells.
- Inhibition of autophagy increased OMT-induced apoptosis, indicating a protective role for autophagy.
- OMT increased HMGB1 expression; HMGB1 inhibition reduced OMT-induced autophagy and increased apoptosis, suggesting HMGB1's role in autophagy regulation via the Akt/mTOR pathway.
Conclusions:
- OMT exhibits antitumor effects on human synovial sarcoma cells, partly through HMGB1-mediated autophagy.
- OMT-induced autophagy is a protective mechanism; its inhibition enhances OMT's cytotoxicity.
- Combining OMT with autophagy or HMGB1 inhibitors may improve treatment efficacy for human synovial sarcoma.
More Related Videos
07:40Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
09:10siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells
Published on: October 28, 2019
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
